DUCTAL CARCINOMA IN-SITU DETECTED IN THE MAMMOGRAPHIC ERA - AN ANALYSIS OF CLINICAL, PATHOLOGICAL, AND TREATMENT-RELATED FACTORS AFFECTING OUTCOME WITH BREAST-CONSERVING THERAPY
Fa. Vicini et al., DUCTAL CARCINOMA IN-SITU DETECTED IN THE MAMMOGRAPHIC ERA - AN ANALYSIS OF CLINICAL, PATHOLOGICAL, AND TREATMENT-RELATED FACTORS AFFECTING OUTCOME WITH BREAST-CONSERVING THERAPY, International journal of radiation oncology, biology, physics, 39(3), 1997, pp. 627-635
Citations number
39
Categorie Soggetti
Oncology,"Radiology,Nuclear Medicine & Medical Imaging
Purpose: We reviewed our institution's experience treating predominant
ly mammographically detected ductal carcinoma in situ (DCIS) with brea
st-conserving therapy (BCT) to determine if any clinical, pathologic,
or treatment-related factors affected outcome. Methods and Materials:
From January 2, 1980 to January 6, 1992, 107 breasts in 105 patients w
ere treated with BCT at William Beaumont Hospital, Royal Oak, MI. All
patients underwent at least an excisional biopsy and 70 patients (65%)
were reexcised. All patients received whole-breast irradiation to a m
edian dose of 50.4 Gy (range 43.1 to 56.0 Gy). Ninety-nine patients (9
3%) received a supplemental boost to the tumor bed for a median total
dose of 60.4 Gy (range 59.1 to 71.8 Gy) using either photons (2 patien
ts), electrons (69 patients),or an interstitial implant (28 patients).
Results: With a median follow-up of 78 months, 10 patients have faile
d in the treated breast for a 5- and 10-year actuarial local control r
ate of 91.2 and 89.8%, respectively. Thirteen percent of the populatio
n have been followed for 10 years or more. Three recurrences were pure
DCIS, and seven were invasive. All patients were salvaged with mastec
tomy. Nine patients remain without evidence of disease a median of 30.
6 months after surgery. One patient failed distantly 36 months after l
ocal recurrence for an ultimate cause specific survival of 99%. Potent
ial clinical (age, mammographic findings, method of detection, etc.),
pathologic (nuclear grade, margins, etc.), and treatment-related facto
rs (dose, boost technique, reexcision status, etc.) affecting outcome
were analyzed. No variable was found to be associated with an ipsilate
ral breast tumor recurrence. However, when only recurrences that occur
red within or immediately adjacent to the lumpectomy cavity were analy
zed, both margin status and the extent off cancerization of lobules (C
OL) near the surgical margin were associated with the development of a
local recurrence. Conclusions: Patients treated with BCT for predomin
antly mammographically detected DCIS achieve excellent rates of local
control and overall survival. Both margin status and the extent of COL
near the surgical margin appear to be associated with recurrences wit
hin or immediately adjacent to the lumpectomy cavity. These data sugge
st that careful attention to the completeness of surgical resection of
DCIS is an important determinant of outcome. (C) 1997 Elsevier Scienc
e Inc.